Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Return on Capital Employed: 2017-2025

Historic Return on Capital Employed for Organogenesis Holdings (ORGO) over the last 8 years, with Sep 2025 value amounting to -0.02%.

  • Organogenesis Holdings' Return on Capital Employed rose 1.00% to -0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.02%, marking a year-over-year increase of 1.00%. This contributed to the annual value of -0.00% for FY2024, which is 4.00% down from last year.
  • Per Organogenesis Holdings' latest filing, its Return on Capital Employed stood at -0.02% for Q3 2025, which was up 63.06% from -0.06% recorded in Q2 2025.
  • Organogenesis Holdings' Return on Capital Employed's 5-year high stood at 0.32% during Q2 2021, with a 5-year trough of -0.06% in Q1 2025.
  • Moreover, its 3-year median value for Return on Capital Employed was -0.00% (2024), whereas its average is 0.00%.
  • In the last 5 years, Organogenesis Holdings' Return on Capital Employed skyrocketed by 54bps in 2021 and then dropped by 19bps in 2022.
  • Organogenesis Holdings' Return on Capital Employed (Quarterly) stood at 0.22% in 2021, then fell by 16bps to 0.06% in 2022, then decreased by 3bps to 0.03% in 2023, then dropped by 4bps to -0.00% in 2024, then grew by 1bps to -0.02% in 2025.
  • Its last three reported values are -0.02% in Q3 2025, -0.06% for Q2 2025, and -0.06% during Q1 2025.